NCOA1 Attenuates High Glucose-Induced Mesangial Matrix Expansion Through ITGA5 Inhibition

Abstract

Objective

To investigate whether nuclear receptor coactivator 1 (NCOA1) participates in the pathogenesis of diabetic kidney disease (DKD) by modulating extracellular matrix (ECM) production in mesangial cells (MCs), and to explore the underlying molecular mechanism.

Methods

The rat glomerular MCs and streptozotocin-induced DKD mouse models were employed. NCOA1 expression was evaluated under both normal and high-glucose conditions. The functional role of NCOA1 was assessed via plasmid-mediated overexpression in high-glucose treated MCs. Integrin alpha 5 (ITGA5) expression was examined in vivo and in vitro, and its regulatory relationship with NCOA1 was investigated. Furthermore, siRNA-mediated knockdown of ITGA5 was performed to determine its necessity in high-glucose driven ECM overproduction.

Results

NCOA1 was abundantly expressed in resting MCs but markedly downregulated upon high-glucose stimulation. Plasmid-driven overexpression of NCOA1 significantly attenuated high-glucose induced ECM protein synthesis. Notably, ITGA5 expression was substantially elevated in the glomerular mesangium of DKD mice and in high-glucose exposed MCs, and this upregulation was negatively governed by NCOA1. Functionally, ITGA5 silencing effectively abrogated the excessive matrix production provoked by high glucose, phenocopying the protective effect of NCOA1 overexpression.

Conclusion

NCOA1 protects against high-glucose induced mesangial expansion in DKD, at least partially, through negative regulation of ITGA5. These findings identify the NCOA1/ITGA5 axis as a potential therapeutic target for counteracting glomerular fibrosis in DKD.

Keywords

Diabetic kidney disease / Mesangial expansion / Nuclear receptor coactivator 1 (NCOA1) / Integrin alpha 5 (ITGA5) / Hyperglycemia / Extracellular matrix

References

[1] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol., 2018, 14(2): 88-98

[2] Hartman RE, Rao PSS, Churchwell MD, et al.. Novel therapeutic agents for the treatment of diabetic kidney disease. Expert Opin Investig Drugs., 2020, 29(11): 1277-1293

[3] Sindhu D, Sharma GS, Kumbala D. Management of diabetic kidney disease: where do we stand?: a narrative review. Medicine., 2023, 102(13 e33366

[4] Steffes MW, Osterby R, Chavers B, et al.. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes., 1989, 38(9): 1077-1081

[5] Walsh CA, Qin L, Tien JC, et al.. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci., 2012, 8(4): 470-485

[6] Guo P, Chen Q, Peng K, et al.. Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling. Oncogene., 2022, 41(20): 2846-2859

[7] Hong Y, Chen Q, Wang Z, et al.. Targeting nuclear receptor coactivator SRC-1 prevents colorectal cancer immune escape by reducing transcription and protein stability of PD-L1. Adv Sci (Weinh)., 2024, 11(33 e2310037

[8] Cacciottolo TM, Henning E, Keogh JM, et al.. Obesity due to steroid receptor coactivator-1 deficiency is associated with endocrine and metabolic abnormalities. J Clin Endocrinol Metab., 2022, 107(6): e2532-e2544

[9] Sun X, Chen J, Chen X, et al.. Nuclear receptor coactivator 3 transactivates proinflammatory cytokines in collagen-induced arthritis. Cytokine., 2023, 161 156074

[10] Peng Q, Hua Y, Xu H, et al.. The NCOA1-CBP-NF-κB transcriptional complex induces inflammation response and triggers endotoxin-induced myocardial dysfunction. Exp Cell Res., 2022, 415(2 113114

[11] Xie Y, Yuan Q, Cao X, et al.. Deficiency of nuclear receptor coactivator 3 aggravates diabetic kidney disease by impairing podocyte autophagy. Adv Sci (Weinh)., 2024, 11(19 e2308378

[12] Lei C, Li M, Qiu Y, et al.. Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1. Cell Death Dis., 2022, 13(2): 184

[13] Lei CT, Tang H, Ye C, et al.. MDM2 contributes to high glucose-induced glomerular mesangial cell proliferation and extracellular matrix accumulation via Notch1. Sci Rep., 2017, 7(1): 10393

[14] Li MR, Lei CT, Tang H, et al.. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy. Int J Biol Sci., 2022, 18(5): 1896-1911

[15] van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res., 2001, 305(3): 285-298

[16] Liu Y, Li Y, Liang J, et al.. The mechanism of leptin on inhibiting fibrosis and promoting browning of white fat by reducing ITGA5 in mice. Int J Mol Sci., 2021, 22(22): 12353

[17] Xu L, Yin L, Tao X, et al.. Dioscin, a potent ITGA5 inhibitor, reduces the synthesis of collagen against liver fibrosis: Insights from SILAC-based proteomics analysis. Food Chem Toxicol., 2017, 107(Pt A): 318-328

[18] Qin L, Xu Y, Xu Y, et al.. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription. Oncotarget., 2015, 6(27): 23890-23904

[19] Qin L, Chen X, Wu Y, et al.. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. Cancer Res., 2011, 71(5): 1742-1751

[20] Leo C, Chen JD. The SRC family of nuclear receptor coactivators. Gene., 2000, 245(1): 1-11

[21] Louet JF, Chopra AR, Sagen JV, et al.. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab., 2010, 12(6): 606-618

[22] Picard F, Géhin M, Annicotte J, et al.. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell., 2002, 111(7): 931-941

[23] Ma X, Xu L, Wang S, et al.. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J Hepatol., 2011, 55(2): 445-452

[24] Mohsen GAM, Abu-Taweel GM, Rajagopal R, et al.. Betulinic acid lowers lipid accumulation in adipocytes through enhanced NCoA1-PPARγ interaction. J Infect Public Health., 2019, 12(5): 726-732

[25] Wang J, Zeng J, Yin G, et al.. Long non-coding RNA FABP5P3/miR-22 axis improves TGFβ1-induced fatty acid oxidation deregulation and fibrotic changes in proximal tubular epithelial cells of renal fibrosis. Cell Cycle., 2023, 22(4): 433-449

[26] Pandolfi F, Franza L, Altamura S, et al.. Integrins: integrating the biology and therapy of cell-cell interactions. Clin Ther., 2017, 39(12): 2420-2436

[27] Kitsiou PV, Tzinia AK, Stetler-Stevenson WG, et al.. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol., 2003, 284(4): F671-F679

[28] Wang X, Zhang Y, Chi K, et al.. IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease. Apoptosis., 2024, 29(7): 1109-1125

Funding

National Natural Science Foundation of China(81800610)

Rights & permissions

The Author(s)

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.